The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
771182916 7711829 16 F 20101013 20160822 20101215 20160824 EXP IT-ROCHE-741874 ROCHE 9.46 YR F Y 42.00000 KG 20160824 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
771182916 7711829 1 PS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) ROACTEMRA - '20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION - INTRAVENOUS USE - VIAL (GLASS) 10 ML' B0001B01 125276 8 MG/KG SOLUTION FOR INFUSION
771182916 7711829 2 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 10 MG/KG SOLUTION FOR INFUSION
771182916 7711829 3 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 8 MG/KG SOLUTION FOR INFUSION
771182916 7711829 4 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 8 MG/KG SOLUTION FOR INFUSION
771182916 7711829 5 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 8 MG/KG SOLUTION FOR INFUSION
771182916 7711829 6 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 8 MG/KG SOLUTION FOR INFUSION
771182916 7711829 7 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 8 MG/KG SOLUTION FOR INFUSION
771182916 7711829 8 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 10 MG SOLUTION FOR INFUSION
771182916 7711829 9 SS Tocilizumab TOCILIZUMAB 1 Intravenous (not otherwise specified) B0001B01 125276 12 MG/KG SOLUTION FOR INFUSION
771182916 7711829 10 C PARACETAMOL ACETAMINOPHEN 1 Unknown ROUTE: ENDORETTAL 0 500 MG TIW
771182916 7711829 11 C PARACETAMOL ACETAMINOPHEN 1 Unknown 0 500 MG BIW
771182916 7711829 12 C TOPAMAX TOPIRAMATE 1 Oral 0 15 MG TABLET BID
771182916 7711829 13 C IBUPROFENE IBUPROFEN 1 Unknown IF PAIN 0 200 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
771182916 7711829 1 Castleman's disease
771182916 7711829 10 Headache
771182916 7711829 12 Headache
771182916 7711829 13 Headache

Outcome of event

Event ID CASEID OUTC COD
771182916 7711829 HO
771182916 7711829 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
771182916 7711829 Abdominal pain upper
771182916 7711829 Arthralgia
771182916 7711829 Headache
771182916 7711829 Malaise
771182916 7711829 Migraine
771182916 7711829 Pachymeningitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
771182916 7711829 1 20100930 20110302 0
771182916 7711829 3 20100331 20121126 0
771182916 7711829 5 20100331 20130726 0
771182916 7711829 6 20130726 20150702 0
771182916 7711829 7 20150702 20151120 0
771182916 7711829 9 20101013 20110302 0
771182916 7711829 10 20110303 20110413 0
771182916 7711829 11 20110413 20110608 0
771182916 7711829 12 20110303 20110331 0
771182916 7711829 13 20131009 0